Browsing by Author "Micic, Sava (7006493137)"
Now showing 1 - 7 of 7
- Results Per Page
- Sort Options
- Some of the metrics are blocked by yourconsent settings
Publication Comparison of open nephroureterectomy and open conservative management of upper urinary tract transitional cell carcinoma(2009) ;Dragicevic, Dejan (6506794751) ;Djokic, Milan (15019194000) ;Pekmezovic, Tatjana (7003989932) ;Vuksanovic, Aleksandar (6602999284) ;Micic, Sava (7006493137) ;Hadzi-Djokic, Jovan (6603561960) ;Tulic, Cane (6602213245) ;Milenkovic, Dragica (7004185511) ;Pljesa-Ercegovac, Marija (16644038900)Simic, Tatjana (6602094386)Introduction: The treatment preserving the kidney for upper urinary tract (UUT) transitional cell carcinoma (TCC) is still controversial. We aimed to elucidate the results of open conservative surgery and compare them with the results of radical nephroureterectomy (RNU). Patients and Methods: The study included 107 patients with UUT TCC treated by open conservative surgery (21 patients) or nephroureterectomy (86 patients). Epidemiological, clinical and pathological characteristics of patients as well as 5-year survival rates were compared between groups. Results: Patients treated by conservative surgery had a significantly higher rate of bilateral tumors (38% vs. 3%, p = 0.0001) and smaller tumor size than those treated by radical operations (2.60 ± 1.24 vs. 3.99 ± 3.94 cm, p = 0.060). Five-year survival rates for patients treated by conservative and radical surgery were 59 and 55%, respectively. Within the group of patients treated by conservative surgery, 5-year overall survival rates of patients operated due to imperative and elective indications were 41 and 75%, respectively. In univariate analysis, RNU was a statistically significant predictor of poorer outcome of the disease in comparison with conservative surgery (HR = 2.2, 95% CI 1.1-4.6, p = 0.030). Conclusions: The mode of operation affects the outcome of UUT TCC patients, in addition to factors such as tumor grade, stage and size. © 2009 S. Karger AG, Basel. - Some of the metrics are blocked by yourconsent settings
Publication Glutathione S-Transferase-P1 Expression Correlates with Increased Antioxidant Capacity in Transitional Cell Carcinoma of the Urinary Bladder(2007) ;Savic-Radojevic, Ana (16246037100) ;Mimic-Oka, Jasmina (56022732500) ;Pljesa-Ercegovac, Marija (16644038900) ;Opacic, Marija (8443925800) ;Dragicevic, Dejan (6506794751) ;Kravic, Tamara (21742880700) ;Djokic, Milan (15019194000) ;Micic, Sava (7006493137)Simic, Tatjana (6602094386)Objectives: Our aim was to perform a comprehensive analysis of the antioxidant capacity of transitional cell carcinoma (TCC) of urinary bladder and discern the role of enzymes associated with glutathione (GSH) in maintaining high GSH levels in these tumours. Because the redox-sensitive protein glutathione S-transferase P1 (GSTP1) might provide an important link between high antioxidant capacity and inhibition of apoptotic pathways, we also explored how the redox state in tumour cells interacts with the expression of GSTP1. Methods: We examined spectrophotometrically the specific activities of GSH-replenishing enzymes involved in GSH synthesis (γ-glutamylcysteine synthetase, γ-GCS), GSH regeneration (glutathione reductase, GR), and antioxidant protection (glutathione peroxidase, GPX; superoxide dismutase, SOD) in the cytosolic fraction of tumours and the surrounding normal tissue of 30 TCC patients. GSTP1-1 expression was also analyzed. Results: We found a significant increase in the activity of both GSH-replenishing and antioxidant enzymes as well as enhanced GSTP1-1 expression in tumours in comparison with adjacent normal uroepithelium. Mean γ-GCS and GR activities in tumours were about 4- and 2-fold higher, respectively, than in corresponding normal tissue. Expression of GSTP1 correlated significantly with GSH level and γ-GCS and GR activities. GPX and SOD activities in TCC were also markedly increased. Conclusions: Enhanced GSH-replenishing pathways account for increased GSH levels in TCC. Upregulated GPX and SOD also contribute to high antioxidant potential in TCC. Under such conditions, expression of redox-sensitive GSTP1 protein is upregulated. © 2007 European Association of Urology. - Some of the metrics are blocked by yourconsent settings
Publication Male oxidative stress infertility (MOSI): Proposed terminology and clinical practice guidelines for management of idiopathic male infertility(2019) ;Agarwal, Ashok (59131293100) ;Parekh, Neel (57196694810) ;Selvam, Manesh Kumar Panner (57200101156) ;Henkel, Ralf (16194084100) ;Shah, Rupin (23470471000) ;Homa, Sheryl T. (6701790948) ;Ramasamy, Ranjith (8574810000) ;Ko, Edmund (54894624400) ;Tremellen, Kelton (6602784728) ;Esteves, Sandro (57208580149) ;Majzoub, Ahmad (55489143500) ;Alvarez, Juan G. (7402573357) ;Gardner, David K. (7402659563) ;Jayasena, Channa N. (8207226900) ;Ramsay, Jonathan W. (7103327153) ;Cho, Chak-Lam (24467362500) ;Saleh, Ramadan (7006807491) ;Sakkas, Denny (7005087689) ;Hotaling, James M. (15757711900) ;Lundy, Scott D. (57200072076) ;Vij, Sarah (57215871662) ;Marmar, Joel (57188543033) ;Gosalvez, Jaime (7005296360) ;Sabanegh, Edmund (6603838743) ;Park, Hyun Jun (55980321500) ;Zini, Armand (7005212511) ;Kavoussi, Parviz (13805293700) ;Micic, Sava (7006493137) ;Smith, Ryan (7410288598) ;Busetto, Gian Maria (37049750600) ;Bakircioǧlu, Mustafa Emre (6602505326) ;Haidl, Gerhard (7007010614) ;Balercia, Giancarlo (56259951900) ;Puchalt, Nicolás Garrido (7006171674) ;Ben-Khalifa, Moncef (57214936021) ;Tadros, Nicholas (6701691160) ;Kirkman-Browne, Jackson (57214933350) ;Moskovtsev, Sergey (6507314741) ;Huang, Xuefeng (55741393700) ;Borges, Edson (7004370399) ;Franken, Daniel (35497885800) ;Bar-Chama, Natan (6602332564) ;Morimoto, Yoshiharu (36051984500) ;Tomita, Kazuhisa (59848616500) ;Srini, Vasan Satya (59662973700) ;Ombelet, Willem (7003971364) ;Baldi, Elisabetta (7006366633) ;Muratori, Monica (7003893334) ;Yumura, Yasushi (7003838923) ;Vignera, Sandro La (8575766400) ;Kosgi, Raghavender (57195955297) ;Martinez, Marlon P. (57214939051) ;Evenson, Donald P. (7006303892) ;Zylbersztejn, Daniel Suslik (55366495600) ;Roque, Matheus (55258695200) ;Cocuzza, Marcello (55385929400) ;Vieira, Marcelo (57214939097) ;Ben-Meir, Assaf (23569561900) ;Orvieto, Raoul (55916977300) ;Levitas, Eliahu (6701473449) ;Wiser, Amir (8599580600) ;Arafa, Mohamed (23098964500) ;Malhotra, Vineet (57215516058) ;Parekattil, Sijo Joseph (6506341654) ;Elbardisi, Haitham (56612024800) ;Carvalho, Luiz (46260942400) ;Dada, Rima (57211027400) ;Sifer, Christophe (6602673729) ;Talwar, Pankaj (35764821800) ;Gudeloglu, Ahmet (29067709500) ;Mahmoud, Ahmed M.A. (57242193900) ;Terras, Khaled (6602072800) ;Yazbeck, Chadi (6603521832) ;Nebojsa, Bojanic (57214934668) ;Durairajanayagam, Damayanthi (55520166400) ;Mounir, Ajina (57214931030) ;Kahn, Linda G. (55356431900) ;Baskaran, Saradha (57210505570) ;Pai, Rishma Dhillon (36713973800) ;Paoli, Donatella (6701544862) ;Leisegang, Kristian (55522599700) ;Moein, Mohamed-Reza (12139250600) ;Malik, Sonia (57225749402) ;Yaman, Onder (56260447200) ;Samanta, Luna (6603697051) ;Bayane, Fouad (57214939367) ;Jindal, Sunil K. (57214937086) ;Kendirci, Muammer (8625690500) ;Altay, Baris (56240034100) ;Perovic, Dragoljub (55843037700)Harlev, Avi (24174157200)Despite advances in the field of male reproductive health, idiopathic male infertility, in which a man has altered semen characteristics without an identifiable cause and there is no female factor infertility, remains a challenging condition to diagnose and manage. Increasing evidence suggests that oxidative stress (OS) plays an independent role in the etiology of male infertility, with 30% to 80% of infertile men having elevated seminal reactive oxygen species levels. OS can negatively affect fertility via a number of pathways, including interference with capacitation and possible damage to sperm membrane and DNA, which may impair the sperm's potential to fertilize an egg and develop into a healthy embryo. Adequate evaluation of male reproductive potential should therefore include an assessment of sperm OS. We propose the term Male Oxidative Stress Infertility, or MOSI, as a novel descriptor for infertile men with abnormal semen characteristics and OS, including many patients who were previously classified as having idiopathic male infertility. Oxidation-reduction potential (ORP) can be a useful clinical biomarker for the classification of MOSI, as it takes into account the levels of both oxidants and reductants (antioxidants). Current treatment protocols for OS, including the use of antioxidants, are not evidence-based and have the potential for complications and increased healthcare-related expenditures. Utilizing an easy, reproducible, and cost-effective test to measure ORP may provide a more targeted, reliable approach for administering antioxidant therapy while minimizing the risk of antioxidant overdose. With the increasing awareness and understanding of MOSI as a distinct male infertility diagnosis, future research endeavors can facilitate the development of evidence-based treatments that target its underlying cause. © 2019 Korean Society for Sexual Medicine and Andrology. All Rights Reserved. - Some of the metrics are blocked by yourconsent settings
Publication Male oxidative stress infertility (MOSI): Proposed terminology and clinical practice guidelines for management of idiopathic male infertility(2019) ;Agarwal, Ashok (59131293100) ;Parekh, Neel (57196694810) ;Selvam, Manesh Kumar Panner (57200101156) ;Henkel, Ralf (16194084100) ;Shah, Rupin (23470471000) ;Homa, Sheryl T. (6701790948) ;Ramasamy, Ranjith (8574810000) ;Ko, Edmund (54894624400) ;Tremellen, Kelton (6602784728) ;Esteves, Sandro (57208580149) ;Majzoub, Ahmad (55489143500) ;Alvarez, Juan G. (7402573357) ;Gardner, David K. (7402659563) ;Jayasena, Channa N. (8207226900) ;Ramsay, Jonathan W. (7103327153) ;Cho, Chak-Lam (24467362500) ;Saleh, Ramadan (7006807491) ;Sakkas, Denny (7005087689) ;Hotaling, James M. (15757711900) ;Lundy, Scott D. (57200072076) ;Vij, Sarah (57215871662) ;Marmar, Joel (57188543033) ;Gosalvez, Jaime (7005296360) ;Sabanegh, Edmund (6603838743) ;Park, Hyun Jun (55980321500) ;Zini, Armand (7005212511) ;Kavoussi, Parviz (13805293700) ;Micic, Sava (7006493137) ;Smith, Ryan (7410288598) ;Busetto, Gian Maria (37049750600) ;Bakircioǧlu, Mustafa Emre (6602505326) ;Haidl, Gerhard (7007010614) ;Balercia, Giancarlo (56259951900) ;Puchalt, Nicolás Garrido (7006171674) ;Ben-Khalifa, Moncef (57214936021) ;Tadros, Nicholas (6701691160) ;Kirkman-Browne, Jackson (57214933350) ;Moskovtsev, Sergey (6507314741) ;Huang, Xuefeng (55741393700) ;Borges, Edson (7004370399) ;Franken, Daniel (35497885800) ;Bar-Chama, Natan (6602332564) ;Morimoto, Yoshiharu (36051984500) ;Tomita, Kazuhisa (59848616500) ;Srini, Vasan Satya (59662973700) ;Ombelet, Willem (7003971364) ;Baldi, Elisabetta (7006366633) ;Muratori, Monica (7003893334) ;Yumura, Yasushi (7003838923) ;Vignera, Sandro La (8575766400) ;Kosgi, Raghavender (57195955297) ;Martinez, Marlon P. (57214939051) ;Evenson, Donald P. (7006303892) ;Zylbersztejn, Daniel Suslik (55366495600) ;Roque, Matheus (55258695200) ;Cocuzza, Marcello (55385929400) ;Vieira, Marcelo (57214939097) ;Ben-Meir, Assaf (23569561900) ;Orvieto, Raoul (55916977300) ;Levitas, Eliahu (6701473449) ;Wiser, Amir (8599580600) ;Arafa, Mohamed (23098964500) ;Malhotra, Vineet (57215516058) ;Parekattil, Sijo Joseph (6506341654) ;Elbardisi, Haitham (56612024800) ;Carvalho, Luiz (46260942400) ;Dada, Rima (57211027400) ;Sifer, Christophe (6602673729) ;Talwar, Pankaj (35764821800) ;Gudeloglu, Ahmet (29067709500) ;Mahmoud, Ahmed M.A. (57242193900) ;Terras, Khaled (6602072800) ;Yazbeck, Chadi (6603521832) ;Nebojsa, Bojanic (57214934668) ;Durairajanayagam, Damayanthi (55520166400) ;Mounir, Ajina (57214931030) ;Kahn, Linda G. (55356431900) ;Baskaran, Saradha (57210505570) ;Pai, Rishma Dhillon (36713973800) ;Paoli, Donatella (6701544862) ;Leisegang, Kristian (55522599700) ;Moein, Mohamed-Reza (12139250600) ;Malik, Sonia (57225749402) ;Yaman, Onder (56260447200) ;Samanta, Luna (6603697051) ;Bayane, Fouad (57214939367) ;Jindal, Sunil K. (57214937086) ;Kendirci, Muammer (8625690500) ;Altay, Baris (56240034100) ;Perovic, Dragoljub (55843037700)Harlev, Avi (24174157200)Despite advances in the field of male reproductive health, idiopathic male infertility, in which a man has altered semen characteristics without an identifiable cause and there is no female factor infertility, remains a challenging condition to diagnose and manage. Increasing evidence suggests that oxidative stress (OS) plays an independent role in the etiology of male infertility, with 30% to 80% of infertile men having elevated seminal reactive oxygen species levels. OS can negatively affect fertility via a number of pathways, including interference with capacitation and possible damage to sperm membrane and DNA, which may impair the sperm's potential to fertilize an egg and develop into a healthy embryo. Adequate evaluation of male reproductive potential should therefore include an assessment of sperm OS. We propose the term Male Oxidative Stress Infertility, or MOSI, as a novel descriptor for infertile men with abnormal semen characteristics and OS, including many patients who were previously classified as having idiopathic male infertility. Oxidation-reduction potential (ORP) can be a useful clinical biomarker for the classification of MOSI, as it takes into account the levels of both oxidants and reductants (antioxidants). Current treatment protocols for OS, including the use of antioxidants, are not evidence-based and have the potential for complications and increased healthcare-related expenditures. Utilizing an easy, reproducible, and cost-effective test to measure ORP may provide a more targeted, reliable approach for administering antioxidant therapy while minimizing the risk of antioxidant overdose. With the increasing awareness and understanding of MOSI as a distinct male infertility diagnosis, future research endeavors can facilitate the development of evidence-based treatments that target its underlying cause. © 2019 Korean Society for Sexual Medicine and Andrology. All Rights Reserved. - Some of the metrics are blocked by yourconsent settings
Publication Survival of patients with transitional cell carcinoma of the ureter and renal pelvis in Balkan endemic nephropathy and non-endemic areas of Serbia(2007) ;Dragicevic, Dejan (6506794751) ;Djokic, Milan (15019194000) ;Pekmezovic, Tatjana (7003989932) ;Micic, Sava (7006493137) ;Hadzi-Djokic, Jovan (6603561960) ;Vuksanovic, Aleksandar (6602999284)Simic, Tatjana (6602094386)OBJECTIVE: To evaluate the characteristics and survival of patients with upper urinary tract (UUT) transitional cell carcinoma (TCC) in Serbia, followed for ≥5 years or until death. PATIENTS AND METHODS: From 1998 to 2005 we analysed 114 cases of pathologically confirmed UUT TCC, divided into two groups according to topographical characteristics, and compared their demographic, clinical and pathological characteristics. The influence of various factors on overall 5-year survival of patients with UUT TCC was also tested. The prognostic value of different variables was assessed by univariate and multivariate Cox proportional-hazard models. RESULTS: The most important change in demographic characteristics of the patients with UUT TCC in Serbia was a similar proportion of patients residing in areas of Balkan endemic nephropathy (BEN) and non-endemic areas. The median (range) follow-up was 67 (46-88) months. The 5-year probability of survival was 51.2 ± 5.8%. There was a significantly lower probability of 5-year survival for patients with a higher histological grade (P = 0.001), higher T stage (P < 0.001) and tumour size >3 cm (P = 0.001) at diagnosis. In this cohort of patients the independent predictors of a poorer outcome of the disease were being female (hazard ratio, HR, 2.2, P = 0.010), tumour size >3 cm (HR 2.8, P = 0.001) and T3 or T4 stages (HR 3.1, P = 0.001). CONCLUSION: Comparative analysis of the characteristics of UUT TCC between patients from BEN and non-endemic areas of Serbia showed similarities in demographic, clinical and pathological features. Factors that significantly influenced survival of patients with UUT TCC were being female, tumour size and tumour grade and stage. © 2007 The Authors. - Some of the metrics are blocked by yourconsent settings
Publication Testis sparing surgery in the treatment of bilateral testicular germ cell tumors and solitary testicle tumors: A single institution experience(2015) ;Bojanic, Nebojsa (55398281100) ;Bumbasirevic, Uros (36990205400) ;Vukovic, Ivan (23500559400) ;Bojanic, Gordana (56378889200) ;Milojevic, Bogomir (36990126400) ;Nale, Djordje (23498496700) ;Durutovic, Otas (6506011266) ;Djordjevic, Dejan (24398182900) ;Nikic, Predrag (55189551300) ;Vuksanovic, Aleksandar (6602999284) ;Tulic, Cane (6602213245)Micic, Sava (7006493137)Background and Objective: To assess the oncologic and functional outcomes of testicular sparing surgery (TSS) based on a single institution experience. Methods: Forty-one patients with bilateral and 3 patients with solitary testicle tumors were referred to our institution. The inclusion criteria for TSS were normal serum testosterone levels, and tumor size (<2 cm). Sperm analysis and hormone status evaluation were performed preoperatively and postoperatively. None of the patients underwent local radiation therapy following TSS for reasons of fertility preservation. Results: A total of 26 TSS were performed in 24 patients. The median follow-up period was 51.0 months. Seven patients developed local recurrence, of which 5 had TIN and were subjected to radical orchiectomy, whereas re-do TSS was done in remaining 2 patients. The overall survival of the study group was 100%, and the presence of testicular intraepithelial neoplasia (TIN) was associated with worse recurrence-free survival (P = 0.031, log-rank). Testosterone values were normal in all of the patients, while 4 patients achieved conception. Conclusions: TSS is acceptable from an oncological point of view, and it enables continuation of a patient's life without lifelong hormonal substitution. Additionally, local irradiation therapy could be delayed in patients with TIN who wish to father children, but with high local recurrence rate. © 2014 Wiley Periodicals, Inc. - Some of the metrics are blocked by yourconsent settings
Publication The correlation of biochemical and morphologic parameters in the assessment of sperm maturity(2013) ;Durutovic, Otas (6506011266) ;Lalic, Natasa (7003905860) ;Milenkovic-Petronic, Dragica (24923372100) ;Bojanic, Nebojsa (55398281100) ;Djordjevic, Dejan (24398182900) ;Milojevic, Bogomir (36990126400) ;Ladjevic, Nebojsa (16233432900) ;Mimic, Ana (55865595300) ;Tulic, Lidija (6504063680) ;Dzamic, Zoran (6506981365)Micic, Sava (7006493137)Objective To examine the relationship between biochemical markers and morphologic sperm characteristics, including head, neck, and tail changes. Methods The study evaluated 154 patients who went to the Andrology Laboratory of the Clinic of Urology, Clinical Center of Serbia. Patients were divided into 4 groups: normozoospermic, oligozoospermic, severe oligozoospermic, and asthenozoospermic, according to the sperm concentration and motility. Results The differences in creatine kinase (CK) and CK-M levels between normozoospermic and the 2 groups of oligozoospermic patients were significantly different (P <.01). The CK and CK-M levels correlated negatively with sperm concentration and sperm motility, but correlated positively with the pathologic sperm form. Patients with CK values >0.093 have a total number of pathologic forms higher than 0.40 (87.5% sensitivity, 77.3% specificity, the area under the curve was 0.832, P <.001). Patients with CK values <0.09 U/L have normal spermatogenesis and pathologic disorder of the head <15%, neck <12%, and tail <10%. Conclusion The relation between sperm morphology and biochemical markers included in the maturation process is established during the sperm genesis process. If the results of these markers are used together with the morphology of the spermatozoa in the interpretation of infertility, it would lead us to better insight of the fertility potential of the each patient. © 2013 Elsevier Inc. All Rights Reserved.